Fulranumab

• UNSPSC Description:

  Fulranumab is a human IgG2 monoclonal antibody against nerve growth factor (NGF) and can be used for the research of pain[1].

• Target Antigen:

  Trk Receptor

• Type:

  Inhibitory Antibodies

• Related Pathways:

  Neuronal Signaling;Protein Tyrosine Kinase/RTK

• Applications:

  Neuroscience-Neuromodulation

• Field of Research:

  Neurological Disease

• Assay Protocol:

  https://www.medchemexpress.com/fulranumab.html

• Purity:

  96.74

• Solubility:

  10 mM in DMSO

• Smiles:

  [Fulranumab]

• References & Citations:

  [1]Dai S, et al. Development of a method that eliminates false-positive results due to nerve growth factor interference in the assessment of fulranumab immunogenicity. AAPS J. 2014 May;16(3):464-77.

• Shipping Conditions:

  Dry Ice

• Storage Conditions:

  Store at -80°C for 2 years

• Clinical Information:

  Phase 3

• CAS Number:

  902141-80-4